Oncogenic microRNA-142-3p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma

Oncology Letters

Volumn 11, Issue 2, 2016, Pages 1235-1241

  Li, Yifan ^a,b   Chen, Duqun ^a,b   Jin, Lu ^a,b   Liu, Jiaju ^a,c   Li, Yuchi ^a,c   Su, Zhengming ^a,c   Qi, Zhengyu ^a   Shi, Min ^a   Jiang, Zhimao ^a   Yang, Shangqi ^a   Gui, Yaoting ^a   Mao, Xiangming ^a   Wu, Xionghui ^a   Lai, Yongqing ^a  

^a PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

microRNA; microRNA 142 3p; Oncogene; Renal cell carcinoma

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; MICRORNA; MICRORNA 142 3P; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENETIC TRANSFECTION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RNA ISOLATION; SEQUENCE ANALYSIS; UPREGULATION; WOUND HEALING;

EID: 84954349636     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.4021     Document Type: Article

References (42)

1. Schaefer A, Stephan C, Busch J, Yousef GM and Jung K: Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors. Nat Rev Urol 7: 286-297, 2010.
2. Garzon R, Calin GA and Croce CM: MicroRNAs in cancer. Annu Rev Med 60: 167-179, 2009.
3. Huntzinger E and Izaurralde E: Gene silencing by microRNAs: Contributions of translational repression and mRNA decay. Nat Rev Genet 12: 99-110, 2011.
4. Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233, 2009.
5. Krol J, Loedige I and Filipowicz W: The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11: 597-610, 2010.
6. Carthew RW and Sontheimer EJ: Origins and mechanisms of miRNAs and siRNAs. Cell 136: 642-655, 2009.
7. Shenouda SK and Alahari SK: MicroRNA function in cancer: Oncogene or a tumor suppressor? Cancer Metastasis Rev 28: 369-378, 2009.
8. Guil S and Esteller M: DNA methylomes, histone codes and miRNAs: Tying it all together. Int J Biochem Cell Biol 41: 87-95, 2009.
9. Ridge CA, Pua BB and Madoff DC: Epidemiology and staging of renal cell carcinoma. Semin Intervent Radiol 31: 3-8, 2014.
10. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
11. Tavani A and La Vecchia C: Epidemiology of renal-cell carcinoma. J Nephrol 10: 93-106, 1997.
12. National Cancer Institute: Surveillance, Epidemiology, and End Results Program. SEER Stat Fact Sheets: Kidney and Renal Pelvis Cancer. http://seer.cancer.gov/statfacts/html/kidrp.html. Accessed March 30, 2014.
13. Patel C, Ahmed A and Ellsworth P: Renal cell carcinoma: A reappraisal. Urol Nurs 32: 182-190, 2012.
14. Lam JS, Leppert JT, Figlin RA and Belldegrun AS: Role of molecular markers in the diagnosis and therapy of renal cell carcinoma. Urology 66 (Suppl): 1-9, 2005.
15. Rini BI, Campbell SC and Escudier B: Renal cell carcinoma. Lancet 373: 1119-1132, 2009.
16. Dias F, Teixeira AL, Santos JI, Gomes M, Nogueira A, Assis J and Medeiros R: Renal cell carcinoma development and miRNAs: A possible link to the EGFR pathway. Pharmacogenomics 14: 1793-1803, 2013.
17. Al-Ali BM, Ress AL, Gerger A and Pichler M: MicroRNAs in renal cell carcinoma: Implications for pathogenesis, diagnosis, prognosis and therapy. Anticancer Res 32: 3727-3732, 2012.
18. Liu H, Brannon AR, Reddy AR, Alexe G, Seiler MW, Arreola A, Oza JH, Yao M, Juan D, Liou LS, et al: Identifying mRNA targets of microRNA dysregulated in cancer: With application to clear cell renal cell carcinoma. BMC Syst Biol 4: 51, 2010.
19. Juan D, Alexe G, Antes T, Liu H, Madabhushi A, Delisi C, Ganesan S, Bhanot G and Liou LS: Identification of a microRNA panel for clear-cell kidney cancer. Urology 75: 835-841, 2010.
20. Yi Z, Fu Y, Zhao S, Zhang X and Ma C: Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues. J Cancer Res Clin Oncol 136: 855-862, 2010.
21. Wu X, Weng L, Li X, Guo C, Pal SK, Jin JM, Li Y, Nelson RA, Mu B, Onami SH, et al: Identification of a 4-microRNA signature for clear cell renal cell carcinoma metastasis and prognosis. PLoS One 7: e35661, 2012.
22. Isobe T, Hisamori S, Hogan DJ, Zabala M, Hendrickson DG, Dalerba P, Cai S, Scheeren F, Kuo AH, Sikandar SS, et al: miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway. eLife 3: 01977, 2014.
23. Colamaio M, Puca F, Ragozzino E, Gemei M, Decaussin-Petrucci M, Aiello C, Bastos AU, Federico A, Chiappetta G, Del Vecchio L, et al: miR-142-3p down-regulation contributes to thyroid follicular tumorigenesis by targeting ASH1L and MLL1. J Clin Endocrinol Metab 100: E59-E69, 2015.
24. Chai S, Tong M, Ng KY, Kwan PS, Chan YP, Fung TM, Lee TK, Wong N, Xie D, Yuan YF, et al: Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133. Oncotarget 5: 5725-5735, 2014.
25. Han J, Yu J and Ling Z: Screening of specific miRNA in early gastric cancer. Zhonghua Wei Chang Wai Ke Za Zhi 17: 175-179, 2014 (In Chinese).
26. Lei Z, Xu G, Wang L, Yang H, Liu X, Zhao J and Zhang HT: MiR-142-3p represses TGF-β -induced growth inhibition through repression of TGFβR1 in non-small cell lung cancer. FASEB J 28: 2696-2704, 2014.
27. Dou L, Li J, Zheng D, Li Y, Gao X, Xu C, Gao L, Wang L and Yu L: MicroRNA-142-3p inhibits cell proliferation in human acute lymphoblastic leukemia by targeting the MLL-AF4 oncogene. Mol Biol Rep 40: 6811-6819, 2013.
28. Lv M, Zhang X, Jia H, Li D, Zhang B, Zhang H, Hong M, Jiang T, Jiang Q, Lu J, et al: An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways. Leukemia 26: 769-777, 2012.
29. Kanaan Z, Roberts H, Eichenberger MR, Billeter A, Ocheretner G, Pan J, Rai SN, Jorden J, Williford A and Galandiuk S: A plasma microRNA panel for detection of colorectal adenomas: A step toward more precise screening for colorectal cancer. Ann Surg 258: 400-408, 2013.
30. Tanaka K, Kondo K, Kitajima K, Muraoka M, Nozawa A and Hara T: Tumor-suppressive function of protein-tyrosine phosphatase non-receptor type 23 in testicular germ cell tumors is lost upon overexpression of miR142-3p microRNA. J Biol Chem 288: 23990-23999, 2013.
31. Lin RJ, Xiao DW, Liao LD, Chen T, Xie ZF, Huang WZ, Wang WS, Jiang TF, Wu BL, Li EM and Xu LY: miR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. J Surg Oncol 105: 175-182, 2012.
32. Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O'Sullivan B, Waldron J, et al: Comprehensive microRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 16: 1129-1139, 2010.
33. Namløs HM, Meza-Zepeda LA, Barøy T, Østensen IH, Kresse SH, Kuijjer ML, Serra M, Bürger H, Cleton-Jansen AM and Myklebost O: Modulation of the osteosarcoma expression phenotype by microRNAs. PLoS One 7: e48086, 2012.
34. Edge SB, Byrd DR, Compton CC, et al: AJCC Cancer Staging Manual. 7th edition. Springer Verlag, New York, NY, USA, pp547-560, 2009.
35. Rydzanicz M, Wrzesiński T, Bluyssen HA and Wesoły J: Genomics and epigenomics of clear cell renal cell carcinoma: Recent developments and potential applications. Cancer Lett 341: 111-126, 2013.
36. Maher ER: Genomics and epigenomics of renal cell carcinoma. Semin Cancer Biol 23: 10-17, 2013.
37. Chow TF, Mankaruos M, Scorilas A, Youssef Y, Girgis A, Mossad S, Metias S, Rofael Y, Honey RJ, Stewart R, et al: The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma. J Urol 183: 743-751, 2010.
38. Shen WW, Zeng Z, Zhu WX and Fu GH: miR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells. J Mol Med (Berl) 91: 989-1000, 2013.
39. Chapnik E, Rivkin N, Mildner A, Beck G, Pasvolsky R, Metzl-Raz E, Birger Y, Amir G, Tirosh I, Porat Z, et al: miR-142 orchestrates a network of actin cytoskeleton regulators during megakaryopoiesis. eLife 3: e01964, 2014.
40. Kaduthanam S, Gade S, Meister M, Brase JC, Johannes M, Dienemann H, Warth A, Schnabel PA, Herth FJ, Sültmann H, et al: Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients. Lung Cancer 80: 223-227, 2013.
41. Wang F, Wang XS, Yang GH, Zhai PF, Xiao Z, Xia LY, Chen LR, Wang Y, Wang XZ, Bi LX, et al: miR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia. Mol Biol Rep 39: 2713-2722, 2012.
42. Mascaux C, Laes JF, Anthoine G, Haller A, Ninane V, Burny A and Sculier JP: Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur Respir J 33: 352-359, 2009.